https://cve.radiocsirt.org/rss/recent/all/10 Most recent entries from all 2026-10-03T17:16:07.799403+00:00 Vulnerability-Lookup csirt@opendfir.org python-feedgen Contains only the most 10 recent entries. https://cve.radiocsirt.org/vuln/euvd-2026-175631 EUVD-2026-175631 2026-10-03T17:16:07.878203+00:00 EUVD-2026-175631 https://cve.radiocsirt.org/vuln/fkie_cve-2021-43935 fkie_cve-2021-43935 2026-10-03T17:16:07.878244+00:00

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

 https://cve.radiocsirt.org/vuln/ghsa-vv5r-9wcq-cqcm GHSA-vv5r-9wcq-cqcm 2026-10-03T17:16:07.878280+00:00

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

 https://cve.radiocsirt.org/vuln/gsd-2021-43935 gsd-2021-43935 2026-10-03T17:16:07.878298+00:00 gsd-2021-43935 https://cve.radiocsirt.org/vuln/icsma-21-343-01 ICSMA-21-343-01 — Hillrom Welch Allyn Cardio Products 2026-10-03T17:16:07.878310+00:00

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.CVE-2021-43935 has been assigned to this vulnerability. A CVSS v3 base score of 8.1 has been calculated; the CVSS vector string is (AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).